These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 5651468)

  • 1. [Study on the action of stelazine on t0ehigher nervous activity of schizophrenics].
    Zakharova NN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(1):98-103. PubMed ID: 5651468
    [No Abstract]   [Full Text] [Related]  

  • 2. Qualitative and quantitative EEG changes of intramuscular thiothixene and trifluoperazine in chronic schizophrenia.
    Akpinar S; Itil TM; Holden JM; Hsu W
    Dis Nerv Syst; 1972 Jan; 33(1):40-5. PubMed ID: 5059688
    [No Abstract]   [Full Text] [Related]  

  • 3. [Importance of trifluoperazine in the process of social readaptation in cases of chronic schizophrenia].
    Cieślik Z; Leczycka K; Thille Z; Trembla K
    Psychiatr Pol; 1969; 3(3):333-9. PubMed ID: 4896422
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy of thought disorder in chronic paranoid schizophrenia: a longitudinal study.
    Wilson IC; Paulson GW; Sandifer MG
    Dis Nerv Syst; 1968 Aug; 29(8):550-1. PubMed ID: 4877898
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute paranoid schizophrenia. (Treatment with chlorpromazine, trifluoperazine and placebo).
    Reardon JD; Abrams S
    Dis Nerv Syst; 1966 Apr; 27(4):265-70. PubMed ID: 5936140
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of tizertsine and triphtazine on higher nervous activity in patients with presenile psychoses].
    Leonova IuI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(12):1878-82. PubMed ID: 4661031
    [No Abstract]   [Full Text] [Related]  

  • 7. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].
    Ozola MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical effects of intramuscular thiothixene and trifluoperazine in chronic schizophrenia: a comparative study.
    Holden JM; Itil TM; Gannon PJ; Keskiner A
    Curr Ther Res Clin Exp; 1971 May; 13(5):298-310. PubMed ID: 4998393
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients).
    Luckey WT; Schiele BC
    Dis Nerv Syst; 1967 Mar; 28(3):181-6. PubMed ID: 4381424
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syndromes.
    Andersen K; d'Elia G; Hållberg B; Perris C; Rapp W; Román G
    Acta Psychiatr Scand Suppl; 1974; 249():43-64. PubMed ID: 4608709
    [No Abstract]   [Full Text] [Related]  

  • 11. [Management of psychotic drive disorders].
    Langner E
    Wien Med Wochenschr; 1968 Sep; 118(36):700-2. PubMed ID: 5679053
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
    Platz AR; Klett CJ; Caffey EM
    Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of Stelazine.
    Lapolla A
    West Med Med J West; 1965 Sep; 6(9):240-5. PubMed ID: 5318895
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
    O'Brien CP; DiGiacomo JN; Webb W
    Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
    Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
    Behav Neuropsychiatry; 1971 Dec; 3(9):6-13. PubMed ID: 4948869
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of laevomepromazine on higher nervous activity in schizophrenia.
    Saarma J; Vasar H; Saarma M
    Act Nerv Super (Praha); 1971; 13(2):89-91. PubMed ID: 5145601
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
    Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oxyhemometric studies of patients with schizophrenia and reactive psychoses while treating them with neuroleptics].
    Timofeev NN; Kondrashenko VT; Nemtseva NIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(6):906-13. PubMed ID: 5723252
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind comparison of molindone and trifluoperazine in the treatment of acute schizophrenia.
    Simpson GM; Amin M; Edwards JG
    J Clin Pharmacol New Drugs; 1971; 11(3):227-36. PubMed ID: 4946101
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual evoked responses and mental status of schizophrenics.
    Heninger G; Speck LB
    Arch Gen Psychiatry; 1966 Oct; 15(4):419-26. PubMed ID: 5954718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.